Q3 2026 Mark Foundation Grantee Publication Highlights

High-impact papers reveal breakthroughs in T cell engineering, spatial tumor biology, and targeted therapeutics

In the third quarter of 2026, Mark Foundation-supported investigators continued to advance cancer discovery and translational science with a collection of high-impact publications across top journals, including Nature, Science, and Cell. Spanning our diverse funding mechanisms, their findings illuminate key mechanisms of anti-tumor immunity, pioneer next-generation CAR T cell engineering and molecular glue strategies, and uncover new epigenetic dependencies in brain and breast cancers.

Explore recent highlights below:

Rb-driven transcription limits its tumour-suppressive effects in breast cancer
Published in Nature by ASPIRE awardee Shom Goel, MD, PhD

In vivo genome-wide CRISPR screens of human T cells in solid tumours
Published in Nature by Endeavor awardees Julia Carnevale, MD; Justin Eyquem, PhD; Alexander Marson, MD, PhD; and Gregory Allen, MD, PhD

Tertiary lymphoid structures harbour stem-like tumour-specific T cells
Published in Nature by Endeavor awardees Catherine Wu, MD and Fei Chen, PhD

Senescence-directed nanotherapy ameliorates fibrosis and overcomes immune exclusion in cancer
Published in Science by Endeavor awardees Scott Lowe, PhD and Paul Romesser, MD

Spatial analysis reveals the evolving organization of IDH-mutant glioma
Published in Cancer Cell by Emerging Leader Award winner Mario Suvà, MD, PhD

Synthetic transcription factors designed by domain recombination enhance CAR T cell antitumor function
Published in Cell by Emerging Leader Award winner Ansuman Satpathy, MD, PhD

Single-nucleus multimodal spatial transcriptomics reveals spatial colocalization of neoantigen-expressing tumor cells and cognate T cells
Published in Nature Biotechnology by Endeavor awardees Catherine Wu, MD; Nir Hacohen, PhD; and Fei Chen, PhD

Systematic Targeting of Protein Complexes with Molecular COUPLrs
Published in Cancer Discovery by Emerging Leader Award winner Liron Bar-Peled, PhD

Divergent medulloblastoma chromatin states disclose KDM2B as a selective dependency
Published in Nature Genetics by Emerging Leader Award winner Paul Northcott, PhD

Recipient Endothelial IRF1 mediates IFNγ-driven tissue tolerance in mouse models of acute Graft-versus-Host Disease
Published in Blood by Momentum Fellow Elizabeth Garfinkle, PhD

Selective decay of interferon mRNAs controls antiviral immunity and innate memory
Published in Molecular Cell by The Mark Foundation Center for Immunotherapy, Immune Signaling, and Radiation

Macrophage restriction in Drosophila wounds and tumors via a matrix degradation–moderating protease inhibitor
Published in Science Advances by ASPIRE awardee David Bilder, PhD

Functional evaluation of TCR-pMHC pairs at scale allows in silico TCR reactivity prediction
Published in Immunity by Cancer Grand Challenges MATCHMAKERS team member Ton Schumacher, PhD

Targeting epigenetic regulators induces transcription-replication conflicts to overcome ATR inhibitor resistance
Published in Nucleic Acids Research by ASPIRE awardee Stephen Jackson, PhD

Back to all